Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes

被引:65
作者
Glaeser, H [1 ]
Drescher, S [1 ]
Eichelbaum, M [1 ]
Fromm, MF [1 ]
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany
关键词
rifampicin; cytochrome P4502C; cytochrome P450 3A4; enterocytes; human small intestine;
D O I
10.1111/j.1365-2125.2004.02265.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To investigate the potential induction by rifampicin of intestinal CYP2C8, CYP2C9, CYP2D6 and CYP3A4 using preparations of human enterocytes. Methods Using a multilumen perfusion catheter shed human enterocytes were collected from 6 healthy subjects before and after 10 days of 600 mg day(-1) oral rifampicin administration. The protein expression of CYP2C8, CYP2C9, CYP2D6 and CYP3A4 as well as that of CYP3A4 mRNA was determined using Western blotting and RT-PCR, respectively. Results CYP3A4 mRNA expression in shed enterocytes increased from 74.6 +/- 44.2 to 143.2 +/- 68.4 a.u. (P < 0.05, 95% CI: 21.8-115.3). Expression of CYP2C8 and CYP2C9 increased from 5.1 +/- 0.9 to 10.4 +/- 2.3 pmol mg(-1) protein (P < 0.01, 95% CI: 2.8-7.7) and from 4.2 +/- 1.4 to 5.7 +/- 1.1 pmol mg(-1) protein (P < 0.01, 95% CI: 0.6-2.4), respectively. No significant difference in CYP2D6 expression before and during rifampicin intake was observed. Rifampicin administration also resulted in a significant induction of CYP3A4 protein (34.1 +/- 10.7 vs. 113.9 +/- 31.1 pmol mg(-1) protein (P < 0.001, 95% CI: 51.8-107.6)). Ex vivo incubation of enterocyte homogenates with verapamil resulted in a significantly increased production of the metabolites formed via CYP3A4 (D-617: 125.9 +/- 118.8 vs. 277.2 +/- 145.5 pmol min(-1) mg(-1) protein (P < 0.05, 95% CI: 30.1-272.5); norverapamil: 113.0 +/- 57.9 vs. 398.4 +/- 148.2 pmol min(-1) mg(-1) protein (P < 0.05, 95% CI: 47.2-523.6)). Conclusion Our findings indicate that shed enterocytes are a useful tool to study the expression, regulation and function of drug metabolizing enzymes. Induction of intestinal CYP2C8 and CYP2C9 might contribute in part to rifampicin - mediated drug interactions, in addition to their hepatic counterparts and intestinal and hepatic CYP3A4.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 43 条
[31]  
Rae JM, 2001, J PHARMACOL EXP THER, V299, P849
[32]   Expression and induction of CYP2CP450 enzymes in primary cultures of human Hepatocytes [J].
Raucy, JL ;
Mueller, L ;
Duan, K ;
Allen, SW ;
Strom, S ;
Lasker, JM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (02) :475-482
[33]   Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine [J].
Suzuki, H ;
Sugiyama, Y .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) :3-12
[34]   Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes:: A comparative analysis in paired tissue specimens [J].
von Richter, O ;
Burk, O ;
Fromm, MF ;
Thon, KP ;
Eichelbaum, M ;
Kivistö, KT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (03) :172-183
[35]   Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique [J].
von Richter, O ;
Greiner, B ;
Fromm, MF ;
Fraser, R ;
Omari, T ;
Barclay, ML ;
Dent, J ;
Somogyi, AA ;
Eichelbaum, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (03) :217-227
[36]   Rapid and highly sensitive method for the determination of verapamil, [2H7]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry [J].
von Richter, O ;
Eichelbaum, M ;
Schönberger, F ;
Hofmann, U .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 738 (01) :137-147
[37]  
WACHER VJ, J PHARM SCI, V87, P1322
[38]   The barrier function of CYP3A4 and P-glycoprotein in the small bowel [J].
Watkins, PB .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 27 (2-3) :161-170
[39]   IDENTIFICATION OF GLUCOCORTICOID-INDUCIBLE CYTOCHROMES-P-450 IN THE INTESTINAL-MUCOSA OF RATS AND MAN [J].
WATKINS, PB ;
WRIGHTON, SA ;
SCHUETZ, EG ;
MOLOWA, DT ;
GUZELIAN, PS .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (04) :1029-1036
[40]   Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction [J].
Westphal, K ;
Weinbrenner, A ;
Zschiesche, M ;
Franke, G ;
Knoke, M ;
Oertel, R ;
Fritz, P ;
von Richter, O ;
Warzok, R ;
Hachenberg, T ;
Kauffmann, HM ;
Schrenk, D ;
Terhaag, B ;
Kroemer, HK ;
Siegmund, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (04) :345-355